Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera

Tom Gordon, Bryon Grove, Joseph C Loftus, Tim O'Toole, Robert McMillan, Jon Lindstrom, Mark H. Ginsberg

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

A cDNA clone was isolated by screening of a λgt11 endothelial expression library with serum from a patient with myasthenia gravis (MG). Rabbit antisera raised against the recombinant protein and human MG sera reactive with the clone immunoblotted an Mr ∼ 250,000 polypeptide (gravin) present in endothelial cells and several adherent cells. Gravin was not detected in platelets, leukocytes, U937, or human erythroleukemic (HEL) cell lines, but was expressed in HEL cells after induction with phorbol myristate acetate. Northern blot analysis showed two transcripts of ∼ 6.7 and 8.4 kb in endothelial cells but not U937 or HEL cells. Indirect immunofluorescence of permeabilized cells revealed a trabecular network of gravin staining with a distinct linear component. Antibodies to gravin were present in sera from 22:72 (31%) of MG patients. In contrast 0:50 normal sera and 1:72 sera from patients with other autoimmune diseases contained antigravin antibodies. Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots. The nucleotide sequence of the immunoreactive clone indicated that it encodes a highly acidic polypeptide fragment that contains the carboxyl terminus of the protein. Neither amino acid nor nucleotide sequences were present in Genbank, EMBL, or Swissprot databases as of March, 1992. These data indicate that gravin is an inducible, cell type-specific cytoplasmic protein and that autoantibodies to gravin may be highly specific for MG.

Original languageEnglish (US)
Pages (from-to)992-999
Number of pages8
JournalJournal of Clinical Investigation
Volume90
Issue number3
StatePublished - 1992
Externally publishedYes

Fingerprint

Myasthenia Gravis
Molecular Cloning
Antigens
Serum
Clone Cells
Peptides
Endothelial Cells
Talin
Microfilament Proteins
Spectrin
Protein Databases
Antibodies
Nucleic Acid Databases
Tetradecanoylphorbol Acetate
Myosins
Indirect Fluorescent Antibody Technique
Recombinant Proteins
Northern Blotting
Autoantibodies
Autoimmune Diseases

Keywords

  • Autoimmunity
  • Cell adhesion
  • Gravin
  • Molecular cloning
  • Myasthenia gravis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gordon, T., Grove, B., Loftus, J. C., O'Toole, T., McMillan, R., Lindstrom, J., & Ginsberg, M. H. (1992). Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. Journal of Clinical Investigation, 90(3), 992-999.

Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. / Gordon, Tom; Grove, Bryon; Loftus, Joseph C; O'Toole, Tim; McMillan, Robert; Lindstrom, Jon; Ginsberg, Mark H.

In: Journal of Clinical Investigation, Vol. 90, No. 3, 1992, p. 992-999.

Research output: Contribution to journalArticle

Gordon, T, Grove, B, Loftus, JC, O'Toole, T, McMillan, R, Lindstrom, J & Ginsberg, MH 1992, 'Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera', Journal of Clinical Investigation, vol. 90, no. 3, pp. 992-999.
Gordon, Tom ; Grove, Bryon ; Loftus, Joseph C ; O'Toole, Tim ; McMillan, Robert ; Lindstrom, Jon ; Ginsberg, Mark H. / Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. In: Journal of Clinical Investigation. 1992 ; Vol. 90, No. 3. pp. 992-999.
@article{1cf84c5cc66b4edcbbca1c5a0800af69,
title = "Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera",
abstract = "A cDNA clone was isolated by screening of a λgt11 endothelial expression library with serum from a patient with myasthenia gravis (MG). Rabbit antisera raised against the recombinant protein and human MG sera reactive with the clone immunoblotted an Mr ∼ 250,000 polypeptide (gravin) present in endothelial cells and several adherent cells. Gravin was not detected in platelets, leukocytes, U937, or human erythroleukemic (HEL) cell lines, but was expressed in HEL cells after induction with phorbol myristate acetate. Northern blot analysis showed two transcripts of ∼ 6.7 and 8.4 kb in endothelial cells but not U937 or HEL cells. Indirect immunofluorescence of permeabilized cells revealed a trabecular network of gravin staining with a distinct linear component. Antibodies to gravin were present in sera from 22:72 (31{\%}) of MG patients. In contrast 0:50 normal sera and 1:72 sera from patients with other autoimmune diseases contained antigravin antibodies. Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots. The nucleotide sequence of the immunoreactive clone indicated that it encodes a highly acidic polypeptide fragment that contains the carboxyl terminus of the protein. Neither amino acid nor nucleotide sequences were present in Genbank, EMBL, or Swissprot databases as of March, 1992. These data indicate that gravin is an inducible, cell type-specific cytoplasmic protein and that autoantibodies to gravin may be highly specific for MG.",
keywords = "Autoimmunity, Cell adhesion, Gravin, Molecular cloning, Myasthenia gravis",
author = "Tom Gordon and Bryon Grove and Loftus, {Joseph C} and Tim O'Toole and Robert McMillan and Jon Lindstrom and Ginsberg, {Mark H.}",
year = "1992",
language = "English (US)",
volume = "90",
pages = "992--999",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera

AU - Gordon, Tom

AU - Grove, Bryon

AU - Loftus, Joseph C

AU - O'Toole, Tim

AU - McMillan, Robert

AU - Lindstrom, Jon

AU - Ginsberg, Mark H.

PY - 1992

Y1 - 1992

N2 - A cDNA clone was isolated by screening of a λgt11 endothelial expression library with serum from a patient with myasthenia gravis (MG). Rabbit antisera raised against the recombinant protein and human MG sera reactive with the clone immunoblotted an Mr ∼ 250,000 polypeptide (gravin) present in endothelial cells and several adherent cells. Gravin was not detected in platelets, leukocytes, U937, or human erythroleukemic (HEL) cell lines, but was expressed in HEL cells after induction with phorbol myristate acetate. Northern blot analysis showed two transcripts of ∼ 6.7 and 8.4 kb in endothelial cells but not U937 or HEL cells. Indirect immunofluorescence of permeabilized cells revealed a trabecular network of gravin staining with a distinct linear component. Antibodies to gravin were present in sera from 22:72 (31%) of MG patients. In contrast 0:50 normal sera and 1:72 sera from patients with other autoimmune diseases contained antigravin antibodies. Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots. The nucleotide sequence of the immunoreactive clone indicated that it encodes a highly acidic polypeptide fragment that contains the carboxyl terminus of the protein. Neither amino acid nor nucleotide sequences were present in Genbank, EMBL, or Swissprot databases as of March, 1992. These data indicate that gravin is an inducible, cell type-specific cytoplasmic protein and that autoantibodies to gravin may be highly specific for MG.

AB - A cDNA clone was isolated by screening of a λgt11 endothelial expression library with serum from a patient with myasthenia gravis (MG). Rabbit antisera raised against the recombinant protein and human MG sera reactive with the clone immunoblotted an Mr ∼ 250,000 polypeptide (gravin) present in endothelial cells and several adherent cells. Gravin was not detected in platelets, leukocytes, U937, or human erythroleukemic (HEL) cell lines, but was expressed in HEL cells after induction with phorbol myristate acetate. Northern blot analysis showed two transcripts of ∼ 6.7 and 8.4 kb in endothelial cells but not U937 or HEL cells. Indirect immunofluorescence of permeabilized cells revealed a trabecular network of gravin staining with a distinct linear component. Antibodies to gravin were present in sera from 22:72 (31%) of MG patients. In contrast 0:50 normal sera and 1:72 sera from patients with other autoimmune diseases contained antigravin antibodies. Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots. The nucleotide sequence of the immunoreactive clone indicated that it encodes a highly acidic polypeptide fragment that contains the carboxyl terminus of the protein. Neither amino acid nor nucleotide sequences were present in Genbank, EMBL, or Swissprot databases as of March, 1992. These data indicate that gravin is an inducible, cell type-specific cytoplasmic protein and that autoantibodies to gravin may be highly specific for MG.

KW - Autoimmunity

KW - Cell adhesion

KW - Gravin

KW - Molecular cloning

KW - Myasthenia gravis

UR - http://www.scopus.com/inward/record.url?scp=0026649419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026649419&partnerID=8YFLogxK

M3 - Article

C2 - 1522245

AN - SCOPUS:0026649419

VL - 90

SP - 992

EP - 999

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -